Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jun. 30, 2021
Operating Activities
Net income (loss)	$ (137,097)	$ 3,789
Adjustments to reconcile net income (loss) to operating activities:
Amortization, depreciation and write-offs	281,677	195,973
Amortization of debt issuance costs and discount	6,820	6,380
Stock-based compensation	101,796	57,103
Change in operating right-of-use asset	10,558	12,267
Loss on settlement of debt	0	16,852
Net unrealized loss (gain) on fair value remeasurements	1,755	(9,855)
Net (gain) loss on foreign currency remeasurements	(1,277)	952
Changes in operating assets and liabilities, net of effect of acquisitions:
Accounts receivable	(163,416)	(69,881)
Prepaid expenses and other current assets	(28,993)	(92,851)
Other assets	3,033	5,269
Accounts payable	13,773	33,936
Operating lease liabilities	(12,046)	(12,083)
Accrued and other liabilities	7,795	6,752
Deferred revenue	(9,286)	(2,327)
Net cash provided by operating activities	75,092	152,276
Investing Activities
Purchase of property and equipment	(400)	(653)
Acquisitions, net of cash acquired	(1,294,352)	(1,017,012)
Purchase of non-marketable investments and other	(56,546)	(14,000)
Proceeds from other investing activities	2,162	10,000
Capitalized software development costs	(2,608)	(1,517)
Net cash used in investing activities	(1,351,744)	(1,023,182)
Financing Activities
Proceeds from Issuance Initial Public Offering	0	1,744,240
Proceeds from debt issuance, net of issuance costs	0	844,729
Payments of debt principal	(9,155)	(706,905)
Payments of finance leases	(12,326)	(4,621)
Proceeds from exercise of stock options	15,873	17,888
Proceeds from the issuance of common stock under the Employee Stock Purchase Plan	3,663	0
Payments of deferred acquisition costs	(71,712)	(157,565)
Payments of licensed asset obligation	(17,374)	0
Repurchases of stock - repurchase program	(244,015)	0
Net cash provided by (used in) financing activities	(335,046)	1,737,766
Effect of foreign exchange rate on cash and cash equivalents	(7,246)	(352)
Net increase (decrease) in cash and cash equivalents	(1,618,944)	866,508
Cash, cash equivalents and restricted cash equivalents at beginning of the period	2,570,504	317,235
Cash and cash equivalents at end of the period	951,560	1,183,743
Supplemental non-cash investing and financing activities disclosures:
Issuance of common stock in connection with an acquisition	137,422	0
Acquisitions not yet paid	70,792	119,256
Assets acquired under finance leases	17,869	2,658
Repurchases of common stock included in accrued liabilities	10,512	0
Issuance of convertible security related to acquisitions	0	342,170
Deferred IPO costs not yet paid	0	986
Supplemental disclosure of cash flow information:
Cash paid for interest on debt	61,867	31,767
Cash paid for income taxes, net of refunds	$ 19,529	$ 32,737